Global bovine respiratory disease treatment market report gives comprehensive outlook on bovine respiratory disease treatment across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report gives historical, current, and future market sizes (US$ Mn) on the basis of disease type, treatment type, end users and region. This report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global bovine respiratory disease treatment market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities). Key stakeholders of the market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global bovine respiratory disease treatment products.
Global Bovine Respiratory Disease Treatment Market Size
The global bovine respiratory disease treatment market estimated to be valued round US$ 66 Mn in 2019 and poised to grow at significant CAGR of 5.1% over 2020-2026. Some of the key factors influencing the market growth include growing demand for bovine respiratory disease treatment due to large consumption of beef and other dairy products. Rising in awareness in people relating these infections make them cautious in taking qualified beef which increases the demand for vaccines and other treatment types of these diseases. Also farm maintainers are also giving more importance to these treatment as these bovine diseases are one of the major cause of the morbidity and mortality in the cattle species.
Benefits offered by bovine respiratory disease treatment are fueling the Market Growth
Bovine respiratory disease treatments helps in early detection of the diseases, prevention of spreading and curing the diseases in the cattle species. According to recent surveys around 45-65% of mortality of cattle occurs due to these bovine infections. Prevention and treatment of these diseases is much more demanded and necessary in these conditions which rises the demand for the bovine respiratory disease treatments. These treatments are majorly required due to the demand for beef and other dairy products.
North America Accounts for Larger Market Revenue Share in Global Bovine Respiratory Disease Treatment Market
North America accounted for larger revenue share in market with considerable CAGR. The growth in this region can be attributed to high consumption of beef in this region, and other dairy products. Presence of large cattle rearing industries, availability of more advanced treatment facilities, more research opportunities, more research funding’s, etc. increases the market for bovine respiratory tract infection treatment market.
- Bayer AG HealthCare
- Bimeda Animal Health
- Boehringer Ingelheim International GmbH
- Inovio Pharmaceuticals
- Intervet Inc.
- Norbrook Laboratories
- Plumbline Life Sciences
- Vetoquinol S.A.,
- Virbac Group.
- Zoetis Services LLC
Global bovine respiratory disease treatment market is surging owing to frequent acquisitions and launchings by the market players. For Instance, on 23 July 2018, AgriLabs Company released the first vaccine (KLEBVax SRP) to prevent mastitis disease caused by Klebsiella pneumoni which was manufactured by them and now is available in market.
Key Findings of the Report:
- Global bovine respiratory disease treatment market expanding at significant CAGR over 2020 to 2026 due to rise in demand for beef products and increase in awareness about the disease treatment.
- Based on treatment type, Vaccines segment in bovine respiratory disease treatments accounted for larger market revenue share in 2019 and projected gain market revenue share over the forecast period
- Players focusing on innovation of newer products and collaboration strategies to retain market position in global bovine respiratory disease treatment market
Key Features of the Report:
- The report provides granular level information about the market size, regional market share, historic market (2015-2019) and forecast (2020-2026)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
By Disease Type
- Lower Respiratory Tract Infections
- Upper Respiratory Tract Infections
By Treatment Type
- Other Treatment Types
By End User
- Veterinary Clinics
- Veterinary Hospitals
- Veterinary Research Institutes
- Private Veterinary
- Rest of Europe
- Australia & New Zealand
- ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
- South Korea
- Rest of Asia-Pacific
- Rest of Latin America
Middle East and Africa (MEA)
- Gulf Cooperation Council (GCC) Countries
- South Africa
- Rest of MEA